Toward a unified therapeutics approach targeting putative amyloid-β oligomer receptors

Ítems similars

• Immunotherapeutic Approaches Targeting Amyloid-β, α-Synuclein, and Tau for the Treatment of Neurodegenerative Disorders
  per: Valera, Elvira, et al.
  Publicat: (2015)
• The many faces of α-synuclein: from structure and toxicity to therapeutic target
  per: Lashuel, Hilal A., et al.
  Publicat: (2013)
• Could changing the course of Alzheimer’s disease pathology with immunotherapy prevent dementia?
  per: Overk, Cassia, et al.
  Publicat: (2019)
• Synaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
  per: Lacor, Pascale N., et al.
  Publicat: (2004)
• Effects of single and combined immunotherapy approach targeting amyloid β protein and α-synuclein in a dementia with Lewy bodies–like model
  per: Mandler, Markus, et al.
  Publicat: (2019)